Overview

Effect of High Dose Ciclesonide on Asthma Control

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The aim of the trial is to investigate asthma control with 160 to 640 mcg ciclesonide/day. Asthma control will be assessed by the Asthma Control Questionnaire (ACQ).

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca
Takeda

Treatments:

Ciclesonide